Colon-26 - Syngeneic Model
Rincon Bio performs Colon-26 syngeneic models to test efficacy of immunotherapies. Please see below for additional information or to request a quote.
Used as a syngeneic model. Implanted tumor cells create a model in which to test the efficacy of novel immunotherapies
Colon-26 cells were derived from a BALB/c mouse. It is a colorectal cancer line and grows as a subcutaneous model
Rincon Bio Growth Curve
WHY WORK WITH
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
Most efficacy studies can be initiated within two business days.
We love our clients. We develop a personal interest in our clients and their studies.